The utility of homologous recombination deficiency biomarkers across cancer types
Shiro Takamatsu, J.B. Brown, Ken Yamaguchi, Junzo Hamanishi, Koji Yamanoi, Hisamitsu Takaya, Tomoko Kaneyasu, Seiichi Mori, Masaki Mandai, Noriomi Matsumura
doi: https://doi.org/10.1101/2021.02.18.21251882
Shiro Takamatsu
1Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
J.B. Brown
2Life Science Informatics Research Unit, Department of Molecular Biosciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Ken Yamaguchi
1Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Junzo Hamanishi
1Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Koji Yamanoi
1Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Hisamitsu Takaya
4Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osaka, Japan
Tomoko Kaneyasu
5Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan
Seiichi Mori
5Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan
Masaki Mandai
1Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Noriomi Matsumura
4Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osaka, Japan
Article usage
Posted February 20, 2021.
The utility of homologous recombination deficiency biomarkers across cancer types
Shiro Takamatsu, J.B. Brown, Ken Yamaguchi, Junzo Hamanishi, Koji Yamanoi, Hisamitsu Takaya, Tomoko Kaneyasu, Seiichi Mori, Masaki Mandai, Noriomi Matsumura
medRxiv 2021.02.18.21251882; doi: https://doi.org/10.1101/2021.02.18.21251882
The utility of homologous recombination deficiency biomarkers across cancer types
Shiro Takamatsu, J.B. Brown, Ken Yamaguchi, Junzo Hamanishi, Koji Yamanoi, Hisamitsu Takaya, Tomoko Kaneyasu, Seiichi Mori, Masaki Mandai, Noriomi Matsumura
medRxiv 2021.02.18.21251882; doi: https://doi.org/10.1101/2021.02.18.21251882
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2296)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11621)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3621)
- Geriatric Medicine (340)
- Health Economics (622)
- Health Informatics (2329)
- Health Policy (918)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (393)
- Neurology (3389)
- Nursing (193)
- Nutrition (512)
- Oncology (1776)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1012)
- Primary Care Research (409)
- Public and Global Health (6019)
- Radiology and Imaging (1237)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)